MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy - Concepedia

Concepedia

Publication | Open Access

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

DOI Full Paper Access

29

Citations

18

References

2024

Year

Sandro Pignata, Daniela Califano, D. Lorusso, Laura Arenare, Michele Bartoletti, Ugo De Giorgi, Claudia Andreetta, Carmela Pisano, Giovanni Scambia, Davide Lombardi,

Annals of Oncology

MedicineMito End-3GynecologyAvelumab ImmunotherapyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentGynecology OncologyEndocrine-related CancerMolecular Profiling

References

	Year	Citations

Page 1

Page 1